It's had far too long a history of half way stories although half way may be overestimating a little too much. 10 years since listing and what $50M ? and they still haven't seen a even a pre-clinical candidate let alone something in clinic. A lot of news that gets no follow through - how's the Bio-Sensor travelling, that must be 2 years since initiated and all it's garnered is maybe half a paragraph in an annual report ? BioLink out-licensing or partnering anti-inflammatory's that must be 2 years ? UOQ SOX18 around a year no update ? Technology partners - IsoGenica, XL Protein, Pepscan < the later was the more interesting but not a peep since it was initiated so unlikely still active. This is only recent years but track back over the 10 years since listing and full of "exciting stories" that vanish or just get replaced by new "exciting stories" - like university groups living of grants - problem is it's shareholders money they are grant shopping off. Unless they pull rabbits out of hats extremely unlikely funds will last out until 2016 but when they moved for the capital it was forecast runway for at least 2 years - same old story. Glad they have Hockings willing to trump money in it must be getting harder to find people to put funds up on another "exciting story" with another deteriorating share price.
Anyway that's my whinge.
PYC Price at posting:
2.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)